# Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer

> **NCT07058805** · PHASE2 · RECRUITING · sponsor: **Olgun Elicin** · enrollment: 50 (estimated)

## Conditions studied

- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma
- Oral Cavity Squamous Cell Carcinoma
- Oropharyngeal Squamous Cell Carcinoma
- Laryngeal Squamous Cell Carcinoma
- Hypopharyngeal Squamous Cell Carcinoma

## Interventions

- **RADIATION:** Compartmentalized Postoperative Radiotherapy

## Key facts

- **NCT ID:** NCT07058805
- **Lead sponsor:** Olgun Elicin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2029-01
- **Final completion:** 2029-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07058805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07058805, "Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07058805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*